Clinical Trials
DFG's Clinical Trials Programme funds high-quality clinical studies to rigorously evaluate new therapeutic, diagnostic, or prognostic methods in patient-oriented research.
Funder: German Research Foundation
Due Dates: Rolling (proposals accepted any time)
Funding Amounts: Feasibility studies: up to €350,000 for max. 36 months; Interventional/observational trials: no fixed cap, initial duration up to 36 months (renewal possible).
Summary: Funds high-quality clinical research projects—interventional and observational—to evaluate new therapeutic, diagnostic, or prognostic methods.
Description
The Clinical Trials Programme of the German Research Foundation (DFG) supports researchers who have completed their academic training in conducting patient-oriented clinical research projects. Funding is available for interventional clinical studies—including feasibility (phase II) and interventional (phase III) trials—as well as for observational trials, provided the research question cannot be answered using an interventional design. The programme aims to rigorously evaluate the efficacy of new therapeutic, diagnostic, or prognostic methods, prioritizing scientific quality, originality, and clinical relevance.
